Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ADVMADMA

Adverum Biotechnologies, Inc.

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ADVM

44/100

ADMA

77/100

Quality

Is it a profitable, well-run business?

ADVM

4.0/10

ADMA

9.8/10

Growth

Is the company growing?

ADVM

0.1/10

ADMA

5.2/10

Valuation

Is the price reasonable? (higher = cheaper)

ADVM

3.3/10

ADMA

6.7/10

Risk

How risky are the shares? (higher = lower risk)

ADVM

4.5/10

ADMA

4.8/10

Momentum

Is the share price trending up?

ADVM

8.2/10

ADMA

7.7/10

Financial strength

Is the balance sheet healthy?

ADVM

2.5/10

ADMA

8.9/10

The balanced view

Model-generated

Adverum Biotechnologies, Inc.

This company scores below average, with a positive price trend and supportive analyst views, although its growth has been slow.

Leads on: momentum

Best feature: positive price trend (RSI (14): 58.2)

Watch out: growth is slow or negative (Revenue growth (FY): -72.2%)

ADMA Biologics, Inc.

This company scores well across most areas, with supportive analyst views and strong profitability.

Leads on: quality, growth, valuation, risk, financial strength

Best feature: analysts broadly positive (Analyst buy share: 90%)

Watch out: weakest area: risk profile (Largest 1Y drawdown: -63%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.